INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INDV INDIVIOR PLC

Trading 01-16 13:42:35 EST

32.66

-0.22

-0.68%

High33.08	Low32.16	Vol975.30K
Open32.75	D1 Closing32.89	Amplitude2.80%
Mkt Cap4.08B	Tradable Cap2.93B	Total Shares124.85M
T/O31.81M	T/O Rate1.09%	Tradable Shares89.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":32.66,"timestamp":1768588952902,"preClose":32.885,"halted":0,"volume":975302,"delay":0,"floatShares":89802878,"shares":124853897,"eps":0.981213,"marketStatus":"Trading","change":-0.225,"latestTime":"01-16 13:42:35 EST","open":32.75,"high":33.08,"low":32.16,"amount":31808222.442231998,"amplitude":0.027976,"askPrice":32.66,"askSize":178,"bidPrice":32.62,"bidSize":485,"shortable":3,"etf":0,"ttmEps":0.981213,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768597200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":32.885,"preHourTrading":{"tag":"盘前","latestPrice":32.91,"preClose":32.885,"latestTime":"09:29 EST","volume":978,"amount":32270.690448,"timestamp":1768573786048},"postHourTrading":{"tag":"盘后","latestPrice":33.27,"preClose":32.885,"latestTime":"19:55 EST","volume":207313,"amount":6817605.305,"timestamp":1768524915394},"volumeRatio":0.686961,"impliedVol":0.5957,"impliedVolPercentile":0.4661},"requestUrl":"/m/hq/s/INDV/wiki","defaultTab":"wiki","newsList":[{"id":"2603982174","title":"Indivior on Track for Record Losing Streak -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982174","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603982174?lang=en_us&edition=fundamental","pubTime":"2026-01-16 01:16","pubTimestamp":1768497360,"startTime":"0","endTime":"0","summary":"Indivior PLC  is currently at $33.14, down $0.50 or 1.47%. --Would be lowest close since Nov. 25, 2025, when it closed at $33.10. --On pace for largest percent decrease since Jan. 13, 2026, when it fell 1.62%. --Currently down eight consecutive days; down 8.59% over this period. --Down 9.47% from its all-time closing high of $36.60 on Dec. 8, 2025. --Up 184.18% from 52 weeks ago , when it closed at $11.66. --Down 9.47% from its 52-week closing high of $36.60 on Dec. 8, 2025. --Traded as low as $32.72; lowest intraday level since Nov. 25, 2025, when it hit $32.54","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Indivior on Track for Record Losing Streak -- Data Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2602519707","title":"Indivior Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2602519707","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602519707?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:27","pubTimestamp":1768217220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INDV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 06:27 ET (11:27 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2602751924","title":"Indivior Plc : H.c. Wainwright Raises Target Price to $48 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2602751924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602751924?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:23","pubTimestamp":1768217024,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2602519197","title":"Indivior price target raised to $48 from $35 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2602519197","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602519197?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:05","pubTimestamp":1768215907,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Indivior (INDV) to $48 from $35 and keeps a Buy rating on the shares. The firm cites the company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indivior-price-target-raised-to-48-from-35-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indivior-price-target-raised-to-48-from-35-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2602323567","title":"Indivior Plc : Stifel Raises Target Price to $42 From $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2602323567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602323567?lang=en_us&edition=fundamental","pubTime":"2026-01-09 16:13","pubTimestamp":1767946424,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA0Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2601393651","title":"Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Indivior (INDV) and GeneDx Holdings (WGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601393651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601393651?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:50","pubTimestamp":1767883840,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quanterix (QTRX – Research Report), Indivior (INDV – Research Rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quanterix-qtrx-indivior-indv-and-genedx-holdings-wgs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quanterix-qtrx-indivior-indv-and-genedx-holdings-wgs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","WGS","LU0029874061.USD","XBI","BK4137","BK4585","HCSG","LABU","LU0128526141.USD","XLV","BK4196","INDV","QTRX","BK4581","BK4007","BK4121"],"gpt_icon":0},{"id":"2601361972","title":"Indivior Expects Up to $1.20 Billion in 2026 Net Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2601361972","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601361972?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:47","pubTimestamp":1767876447,"startTime":"0","endTime":"0","summary":"Indivior  said Thursday it expects $1.13 billion to $1.20 billion for 2026 net revenue, reflecting expected revenue growth from its Sublocade treatment for opioid use disorder.Analysts polled by FactSet expect $1.13 billion.The company said it expects Sublocade net revenue to increase by 11% in 2026, to between $905 million to $945 million, driven by dispense unit growth and expected margin expansion.Shares of Indivior were up more than 1% in recent premarket activity Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2601369458","title":"GUIDANCE: (INDV) Indivior Expects 2026 Revenue Range $1.13B - $1.2B, vs. FactSet Est of $1.19B","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369458","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369458?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:23","pubTimestamp":1767874980,"startTime":"0","endTime":"0","summary":"GUIDANCE: (INDV) Indivior Expects 2026 Revenue Range $1.13B - $1.2B, vs. FactSet Est of $1.19B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INDV"],"gpt_icon":0},{"id":"2601136647","title":"Indivior plc joins S&P SmallCap 600 index","url":"https://stock-news.laohu8.com/highlight/detail?id=2601136647","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601136647?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873618,"startTime":"0","endTime":"0","summary":"Indivior plc will be added to the S&P SmallCap 600 index effective December 22, 2025. The document does not specify the reason for the inclusion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL5d14yk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","LU2210149790.SGD","INDV","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD","NDAQ","BK4007","SG9999014005.SGD","SG9999014013.SGD","BK4588","BK4585","SG9999014039.USD"],"gpt_icon":0},{"id":"2601383266","title":"Director Barbara Ryan acquires common shares of Indivior plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2601383266","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601383266?lang=en_us&edition=fundamental","pubTime":"2026-01-08 02:52","pubTimestamp":1767811940,"startTime":"0","endTime":"0","summary":"Barbara Ryan, Director at Indivior plc, has reported the acquisition of common shares of Indivior plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL27CpDK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2601834353","title":"Indivior Director David E. Wheadon Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601834353","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601834353?lang=en_us&edition=fundamental","pubTime":"2026-01-08 02:47","pubTimestamp":1767811652,"startTime":"0","endTime":"0","summary":"David E. Wheadon, Director, reported the acquisition of common shares of Indivior plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL9rDwxs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2601383395","title":"Indivior plc Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Woodrow D. Anderson","url":"https://stock-news.laohu8.com/highlight/detail?id=2601383395","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601383395?lang=en_us&edition=fundamental","pubTime":"2026-01-08 02:25","pubTimestamp":1767810327,"startTime":"0","endTime":"0","summary":"Indivior plc has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Woodrow D. Anderson, Chief Accounting Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL61Whqj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Indivior plc Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Woodrow D. Anderson","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"gpt_icon":0},{"id":"2593412373","title":"Has Indivior’s 192% Surge in 2025 Already Priced In Its Growth Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412373","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593412373?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:13","pubTimestamp":1766495617,"startTime":"0","endTime":"0","summary":"If you are wondering whether Indivior is still worth buying after a huge run up, you are not alone. This article will walk through what the current price really implies.\nThe stock has climbed about 3.0% over the last week, 11.3% over the past month, and an eye catching 191.6% year to date, with a 204.0% gain over the last year underscoring how quickly sentiment has shifted.\nInvestors have been reacting to a stream of updates around Indivior's positioning in treatments for opioid use disorder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/has-indiviors-192-surge-in-2025-already-priced-in-its-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/has-indiviors-192-surge-in-2025-already-priced-in-its-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","INDV","BK4007"],"gpt_icon":0},{"id":"2593484004","title":"Indivior plc Joins S&P SmallCap 600 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2593484004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593484004?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:02","pubTimestamp":1766404977,"startTime":"0","endTime":"0","summary":"Indivior plc will be added to the S&P SmallCap 600 index. The company’s inclusion reflects its sharpened U.S. business profile and aligns its capital markets presence accordingly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via PR Newswire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL8tJJNd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2593126232","title":"Indivior (NasdaqGS:INDV): Reassessing Valuation After Positive SUBLOCADE and INDV-2000 Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2593126232","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593126232?lang=en_us&edition=fundamental","pubTime":"2025-12-21 14:16","pubTimestamp":1766297771,"startTime":"0","endTime":"0","summary":"Indivior (NasdaqGS:INDV) just gave investors fresh reasons to revisit the stock, with new clinical data on SUBLOCADE and Phase II results for INDV-2000 underscoring progress in treating high risk opioid use disorder.\nSee our latest analysis for Indivior.\nThose encouraging readouts help explain why Indivior’s 90 day share price return sits at 51.31 percent and its 1 year total shareholder return is 201.97 percent, suggesting momentum is building around the story.\nIf this kind of clinical...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/indivior-nasdaqgsindv-reassessing-valuation-after-positive-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/indivior-nasdaqgsindv-reassessing-valuation-after-positive-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007","DCF"],"gpt_icon":0},{"id":"2592181974","title":"Indivior Raises CEO and CFO Base Salaries for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2592181974","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592181974?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:06","pubTimestamp":1766091964,"startTime":"0","endTime":"0","summary":"Indivior plc has approved new base salary increases for its top executive officers, effective January 1, 2026. Chief Executive Officer Joseph Ciaffoni’s annual base salary will rise from $1,050,000 to $1,115,000. Chief Financial Officer Ryan Preblick’s base salary will increase from $559,000 to $604,000. These changes were based on a review of the competitive market and recommendations from the company’s Compensation Committee and its consultant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9zhYvx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2592974569","title":"The Bull Case For Indivior (INDV) Could Change Following New SUBLOCADE Fentanyl-User Efficacy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2592974569","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592974569?lang=en_us&edition=fundamental","pubTime":"2025-12-18 17:25","pubTimestamp":1766049938,"startTime":"0","endTime":"0","summary":"Indivior PLC recently reported positive randomized, double-blind clinical trial results showing that both 100-mg and 300-mg monthly maintenance doses of SUBLOCADE® reduced opioid use and supported abstinence in people with moderate-to-severe opioid use disorder, without new safety signals.\nA key insight from the post-hoc analyses was that the 300-mg monthly dose outperformed the 100-mg dose in participants with high-frequency fentanyl use, underlining SUBLOCADE®’s potential relevance for...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/the-bull-case-for-indivior-indv-could-change-following-new-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/the-bull-case-for-indivior-indv-could-change-following-new-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2592914539","title":"Indivior Study Finds 300-mg SUBLOCADE Dose More Effective for High-Frequency Fentanyl Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2592914539","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592914539?lang=en_us&edition=fundamental","pubTime":"2025-12-18 00:30","pubTimestamp":1765989020,"startTime":"0","endTime":"0","summary":"Indivior plc announced results from a randomized, double-blind clinical trial published in JAMA Network Open evaluating extended-release buprenorphine  for moderate-to-severe opioid use disorder. The study found that both 100-mg and 300-mg monthly maintenance doses of SUBLOCADE rapidly reduced opioid use and improved abstinence, with no new safety signals identified. Post-hoc analyses indicated the 300-mg dose performed significantly better than the 100-mg dose in participants reporting high-frequency fentanyl use. Injection-site reactions were more common at the higher dose but were mild to moderate and did not lead to discontinuation. The results have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLb3x9Px:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2591210936","title":"Indivior plc Held Shareholder Meeting on Scheme of Arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2591210936","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591210936?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:05","pubTimestamp":1765832701,"startTime":"0","endTime":"0","summary":"Indivior plc held two shareholder meetings on December 11, 2025, to vote on matters related to the Scheme of Arrangement. Proposals included authorizing the directors to take all necessary actions to implement the Scheme of Arrangement, approving the reduction of share capital, and authorizing the allotment and issuance of new Indivior shares. All proposals were approved by the shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL2Ss55N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"gpt_icon":0},{"id":"2590633775","title":"Indivior (INDV): Assessing Valuation After Strong SUBLOCADE Growth, Raised Guidance and Newtyn’s Big Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=2590633775","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590633775?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:28","pubTimestamp":1765416509,"startTime":"0","endTime":"0","summary":"Newtyn Management’s decision to boost its stake in Indivior (INDV) and make it the fund’s largest holding came right as the company reported a 15% jump in SUBLOCADE sales and raised full year guidance.\nSee our latest analysis for Indivior.\nInvestors have been quick to price in that stronger SUBLOCADE trajectory and cost reset, with the share price delivering a 30 day return of 14.8 percent and a powerful year to date share price return of 183.6 percent. This reinforces a clear, momentum...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/indivior-indv-assessing-valuation-after-strong-sublocade-gro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior/news/indivior-indv-assessing-valuation-after-strong-sublocade-gro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4007","INDV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indivior.com","stockEarnings":[{"period":"1week","weight":-0.0739},{"period":"1month","weight":-0.0705},{"period":"3month","weight":0.3433},{"period":"6month","weight":1.054},{"period":"1year","weight":1.8349},{"period":"ytd","weight":-0.0835}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.103},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.016069},{"month":2,"riseRate":0.636364,"avgChangeRate":0.019695},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.0019},{"month":4,"riseRate":0.818182,"avgChangeRate":0.02245},{"month":5,"riseRate":0.909091,"avgChangeRate":0.072883},{"month":6,"riseRate":0.454545,"avgChangeRate":0.053237},{"month":7,"riseRate":0.8,"avgChangeRate":0.171847},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.014379},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.095405},{"month":10,"riseRate":0.363636,"avgChangeRate":0.007009},{"month":11,"riseRate":0.545455,"avgChangeRate":0.010295},{"month":12,"riseRate":0.636364,"avgChangeRate":0.020229}],"exchange":"NASDAQ","name":"INDIVIOR PLC","nameEN":"INDIVIOR PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INDIVIOR PLC(INDV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INDIVIOR PLC,INDV,INDIVIOR PLC股票,INDIVIOR PLC股票老虎,INDIVIOR PLC股票老虎国际,INDIVIOR PLC行情,INDIVIOR PLC股票行情,INDIVIOR PLC股价,INDIVIOR PLC股市,INDIVIOR PLC股票价格,INDIVIOR PLC股票交易,INDIVIOR PLC股票购买,INDIVIOR PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INDIVIOR PLC(INDV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction